Malignancy, mortality, and medicosurgical management of Clostridium septicum infection

Surgery. 1995 Oct;118(4):592-7; discussion 597-8. doi: 10.1016/s0039-6060(05)80023-6.

Abstract

Background: Necrotizing Clostridium septicum infections (CSI) have a strong association with malignancy or immunosuppression. To clarify this relationship and determine how it impacted mortality, the experience with CSI at a single institution was reviewed.

Methods: Records of all patients admitted to our hospital with culture proven clostridial infection from 1966 through 1993 were reviewed.

Results: Among patients presenting with clinical gas gangrene, 281 had culture proven clostridial infection and 32 (11.4%) had CSI. The mortality among CSI patients was 56%, whereas 26% of all patients with clostridial infections died (p = 0.001). An associated malignancy was found in 50% of patients with CSI, whereas this was seen in only 11% of patients with other clostridial infections (p = 0.0001 for CSI versus clostridial infection overall). The remaining patients with spontaneous CSI all had evidence of immunosuppression.

Conclusions: The high mortality and likelihood of associated malignancy or hematologic disease underscore the importance of a high index of suspicion and the need to search for and treat associated conditions in all patients with CSI.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenocarcinoma / complications
  • Adult
  • Aged
  • Aged, 80 and over
  • Amputation, Surgical
  • Anti-Bacterial Agents
  • Cecal Neoplasms / complications
  • Combined Modality Therapy
  • Debridement
  • Drug Therapy, Combination / therapeutic use
  • Female
  • Gas Gangrene / complications
  • Gas Gangrene / epidemiology*
  • Gas Gangrene / pathology
  • Gas Gangrene / surgery
  • Gas Gangrene / therapy
  • Hematologic Diseases / complications
  • Humans
  • Hyperbaric Oxygenation
  • Immunocompromised Host
  • Male
  • Middle Aged
  • Necrosis
  • Neoplasms / complications*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents